Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chantix for Alcohol Use Disorder
NCT03035708Phase 2Completed
- Sponsor
- National Institute on Alcohol Abuse and Alcoholism
- Start
- May 2017
- Primary completion
- Jul 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of varenicline in alcohol use disorder (AUD), sponsored by National Institute on Alcohol Abuse and Alcoholism. Started May 2017; status: completed.
02
Drugs
varenicline
03
Conditions
alcohol use disorder (AUD)
Beyond the preview
Go deeper on NCT03035708.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03035708.